MADRIGAL PHARMACEUTICALS, INC. (MDGL) Net margin 2024–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) net profit margin by fiscal year — reported net income divided by reported revenue.
-30.1%FY2025 · since FY2024: -258.6% → -30.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -30.1% | +228.6 pp |
| FY2024 | -258.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MDGL financial trends
MDGL RevenueMDGL Net incomeMDGL Gross profitMDGL Gross marginMDGL Operating incomeMDGL Operating marginMDGL Operating cash flowMDGL Free cash flowMDGL Capital expendituresMDGL Return on equityMDGL Stock buybacksMDGL Dividends paidMDGL Total assetsMDGL Total liabilitiesMDGL Shareholders’ equityMDGL overview →